-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-09-21
The reference study identifies ALDOB K87 lactylation as a mechanistic link between hypoxia-driven glycolysis, mitochondrial fission, and pulmonary artery smooth muscle cell remodeling. Its lactate–ALDOB–DRP1 model provides a framework for studying how metabolic post-translational modifications may sustain pulmonary hypertension, while also highlighting experimental limitations that matter for translation.
-
Ruxolitinib phosphate: JAK/STAT Assay Guide
2026-09-21
Ruxolitinib phosphate enables controlled JAK1/JAK2 inhibition for cytokine-response assays, autoimmune disease models, and mechanistic cancer studies. This guide translates the ATC findings on STAT3, DRP1, mitochondrial dynamics, apoptosis, and GSDME-mediated pyroptosis into practical workflows and troubleshooting decisions.
-
Methotrexate Workflows for Mechanistic Research
2026-09-20
Turn Methotrexate’s DHFR inhibition, intracellular polyglutamate formation, and immunomodulatory activity into interpretable cell and permeability assays. This guide pairs practical dosing and troubleshooting with biomimetic chromatography choices for apoptosis, inflammation, and membrane-partitioning studies.
-
Dabigatran: From Thrombin Assays to Outcomes
2026-09-19
Dabigatran research is most informative when molecular potency, coagulation function tests, and clinically meaningful endpoints are interpreted as connected but distinct layers. This guide uses Pradaxa pharmacology and lessons from the VERTIS CV trial to develop a more rigorous framework for translational anticoagulation assays.
-
Chloramphenicol: From Selection to Plasmid Insight
2026-09-18
Chloramphenicol is more than a selection antibiotic: it can anchor a layered strategy for interpreting plasmid maintenance, gene mobility, and assay phenotype. This article connects molecular reagent design with evidence from recent carbapenemase-transmission research.
-
Dabigatran Safety: Evidence and Adverse-Event Management
2026-09-18
The reference study reviews published evidence on Dabigatran-associated adverse events and translates case-report patterns into practical risk-management recommendations. Its main contribution is a clinically focused framework linking direct thrombin inhibition with bleeding, gastrointestinal and esophageal injury, organ impairment, allergic reactions, and possible cardiovascular complications.
-
Prevotella copri, IPyA, and Breast Cancer Progression
2026-09-17
This study identifies Prevotella copri as a gut microbial factor that can accelerate breast cancer growth by consuming tryptophan and depleting host indole-3-pyruvic acid (IPyA). Its mechanistic model connects microbial metabolism with UHRF1-associated AMPK inactivation, providing a framework for studying microbiota–metabolite effects in tumor progression.
-
Selonsertib (GS-4997) for Autophagy Stress Assays
2026-09-17
Use Selonsertib (GS-4997) to separate ASK1-driven oxidative stress signaling from the Galectin-1–FIP200 autophagy defect in metabolic liver models. This practical workflow combines pathway pharmacology, autophagic-flux measurements, lipid phenotyping, and troubleshooting guidance for NAFLD, fibrosis, and related stress biology.
-
Diminazene Aceturate: From Target to Phenotype
2026-09-16
Diminazene Aceturate is a versatile research compound for separating trypanosome biology from ACE2-linked cardiac phenotypes. This guide focuses on assay decisions, mechanistic interpretation, and the limits of translating pharmacological findings across research domains.
-
Phosbind Acrylamide: Phosphate-Binding SDS-PAGE
2026-09-16
Phosbind Acrylamide is a MnCl2-containing phosphate-binding reagent for antibody-free protein phosphorylation analysis by SDS-PAGE. Its product information supports use near neutral physiological pH and for protein targets in the 30–130 kDa range, while a 2026 apple study provides a biologically relevant phosphorylation-signaling use case.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-15
Carbenoxolone disodium (SKU A8389) is a research reagent for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell and tissue assays. It is best used with vehicle, viability, and orthogonal pathway controls, not as a selective target-validation compound or an established in vivo efficacy treatment.
-
Epalrestat for Polyol Pathway and Fructose Research
2026-09-15
Epalrestat provides a practical chemical probe for connecting aldose reductase activity with endogenous fructose production, oxidative stress, and disease-relevant phenotypes. This workflow shows how to use it in cancer-metabolism assays while distinguishing established diabetic and neuroprotection applications from emerging oncology hypotheses.
-
Tranexamic Acid: Assay Design for Fibrinolysis
2026-09-14
Tranexamic Acid is more than a clot-stabilizing reagent: its concentration-dependent biology can guide biochemical, cellular, and biomaterial assay design. This article translates published TXA dressing findings into practical decisions for reproducible fibrinolysis research.
-
Boc-D-FMK Workflow for Apoptosis Research
2026-09-14
Boc-D-FMK provides a practical way to test whether caspase activity connects apoptotic injury with TNF-driven inflammation. This workflow combines cell-based rescue experiments, renal endothelial and hepatocyte models, and a precision assay strategy informed by recent glioblastoma research.
-
L-NAME Hydrochloride: NOS Assay Workflows
2026-09-13
Build reproducible nitric oxide synthase inhibition assays with L-NAME Hydrochloride, from cell-based screening to vascular tone regulation studies. A practical framework connects NOS perturbation with the FXR–KLF11–JAK2/STAT3 findings reported in contrast-induced acute kidney injury research while separating established evidence from testable extensions.